CHICAGO, June 7 /PRNewswire/ -- EvoLife Laboratories, a world leader in the development of innovative products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy treatments, successfully launched its products in USA in 2010. EvoLife Laboratories is present at the annual American Association of Clinical Oncology (ASCO) Congress 2010 in Chicago and utilizes this opportunity to engage with oncologists and caregivers to support the goal of ASCO -- "advancing quality through innovation."
EvoLife's Commitment to Supportive Cancer Care
Quality of life affected by chemotherapy and radiation therapy side-effects among patients and lack of products to address these problems continues to pose a serious challenge for patients, oncologists, dermatologists, nurses, and other caregivers involved with treatment. Live from the floors of ASCO, leading oncologist, Dr. Robert Fisher, MD, said "Most clinicians have patients with cutaneous and oral side effects resulting from therapy. I am sure all oncologists like me and many patients will benefit from EvoLife products. I am excited and hopeful about having my patients try these products."
EvoLife is committed to improving the overall quality of life of these patients through an innovative product line that ensures and increases their ability to undergo and stay on the treatment regimen. EvoLife products "contain a unique blend of natural minerals which have shown to assist patients by providing ultimate hydration and protection as well as improve their daily life. They are the first and only products of their kind that are effective, uniquely designed with the needs of cancer patients in mind and well tested - "The Neurogenic Component of Cutaneous Toxicities Induced by Chemotherapy – New Solutions. J. F. Chanez. European Oncology, Vol 6:1, 28 – 30."
Oncology Treatment Center and Industry Feedback
"The niche market has deepened due to the increasing use of targeted therapies. Some chemo causes terrible rashes and acne on face and neck," says Ann Richards, supervisor at the Mayo Clinic Erickson Hair and Skin Care Center. "Patients don't know what to do about it."
Carrie Mellage, director of consumer products for Kline & Company market research, noted that with all the changes cancer patients must deal with, adjusting their personal-care regimen may not be a top priority. But she does see growth potential. "There is a definite opportunity here," Mellage said. "EvoLife appears to be a relevant and empathetic brand, and could certainly be successful in its own right." EvoLife already has plans to extend its portfolio, with sunscreen and toothpaste innovations in the pipeline – The Rose Sheet Vol. 31, No. 17, April 2010.
SOURCE EvoLife Laboratories